These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 6336600

  • 1. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA, Lopez-Ovejero JA, Drayer JI, Case DB, Laragh JH.
    Arch Intern Med; 1977 Mar 29; 137(3):284-9. PubMed ID: 843146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium antagonists and thiazide diuretics in the treatment of hypertension.
    Ferrara LA, Pasanisi F, Marotta T, Rubba P, Mancini M.
    J Cardiovasc Pharmacol; 1987 Mar 29; 10 Suppl 10():S136-7. PubMed ID: 2455115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension].
    Rhomberg F.
    Schweiz Med Wochenschr; 1977 Sep 03; 107(35):1228-32. PubMed ID: 335498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN, Zweifler AJ, Hansson L, Schork MA, Ellis C.
    Aust N Z J Med; 1975 Feb 03; 5(1):17-24. PubMed ID: 1057909
    [Abstract] [Full Text] [Related]

  • 19. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F, Belogi M, Ansuini R, Campolucci G.
    Pharmatherapeutica; 1983 Feb 03; 3(7):475-81. PubMed ID: 6366805
    [Abstract] [Full Text] [Related]

  • 20. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP, Peacock PB.
    Arch Intern Med; 1984 Apr 03; 144(4):710-4. PubMed ID: 6712367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.